292 related articles for article (PubMed ID: 21210239)
1. CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target.
Terasaki M; Sugita Y; Arakawa F; Okada Y; Ohshima K; Shigemori M
Brain Tumor Pathol; 2011 Apr; 28(2):89-97. PubMed ID: 21210239
[TBL] [Abstract][Full Text] [Related]
2. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
3. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling.
Goffart N; Kroonen J; Di Valentin E; Dedobbeleer M; Denne A; Martinive P; Rogister B
Neuro Oncol; 2015 Jan; 17(1):81-94. PubMed ID: 25085362
[TBL] [Abstract][Full Text] [Related]
4. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
Kucia M; Jankowski K; Reca R; Wysoczynski M; Bandura L; Allendorf DJ; Zhang J; Ratajczak J; Ratajczak MZ
J Mol Histol; 2004 Mar; 35(3):233-45. PubMed ID: 15339043
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
[TBL] [Abstract][Full Text] [Related]
6. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
Teicher BA; Fricker SP
Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
[TBL] [Abstract][Full Text] [Related]
8. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
[TBL] [Abstract][Full Text] [Related]
9. Expression of chemokine CXCL12 and its receptor CXCR4 in folliculostellate (FS) cells of the rat anterior pituitary gland: the CXCL12/CXCR4 axis induces interconnection of FS cells.
Horiguchi K; Ilmiawati C; Fujiwara K; Tsukada T; Kikuchi M; Yashiro T
Endocrinology; 2012 Apr; 153(4):1717-24. PubMed ID: 22355073
[TBL] [Abstract][Full Text] [Related]
10. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
11. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
[TBL] [Abstract][Full Text] [Related]
12. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
Kioi M; Vogel H; Schultz G; Hoffman RM; Harsh GR; Brown JM
J Clin Invest; 2010 Mar; 120(3):694-705. PubMed ID: 20179352
[TBL] [Abstract][Full Text] [Related]
14. Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas.
Greenfield JP; Cobb WS; Lyden D
J Clin Invest; 2010 Mar; 120(3):663-7. PubMed ID: 20179347
[TBL] [Abstract][Full Text] [Related]
15. CXCL12/CXCR4 promotes motility and proliferation of glioma cells.
do Carmo A; Patricio I; Cruz MT; Carvalheiro H; Oliveira CR; Lopes MC
Cancer Biol Ther; 2010 Jan; 9(1):56-65. PubMed ID: 19923906
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor CXCR4: role in gastrointestinal cancer.
Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
[TBL] [Abstract][Full Text] [Related]
17. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
19. Expression of the new CXCL12 receptor, CXCR7, in gliomas.
Calatozzolo C; Canazza A; Pollo B; Di Pierro E; Ciusani E; Maderna E; Salce E; Sponza V; Frigerio S; Di Meco F; Schinelli S; Salmaggi A
Cancer Biol Ther; 2011 Jan; 11(2):242-53. PubMed ID: 21084856
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 in breast cancer: oncogenic role and therapeutic targeting.
Xu C; Zhao H; Chen H; Yao Q
Drug Des Devel Ther; 2015; 9():4953-64. PubMed ID: 26356032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
